Corporativo Fragua S.A.B. de C.V (FRAGUAB) fair value: what the stock is really worth
As of Nov 3, 2026: fair value (intrinsic value) of Corporativo Fragua S.A.B. de C.V stock MXN 745, price MXN 415, upside +79.4%, quality 53 out of 100. Rating: strongly undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 1, 2026.
How to read this chart
60‑month range 270.33 MXN – 982.73 MXN · fair‑value band 394.62 MXN – 1,147 MXN · the 415.00 MXN price screens below the 744.58 MXN fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 1, 2026.
Follow Corporativo Fragua S.A.B. de C.V in your weekly email
Every Wednesday you see whether Corporativo Fragua S.A.B. de C.V is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Corporativo Fragua, S.A.B. de C.V., together with its subsidiaries, operates pharmacy stores in Mexico. The company purchases and sells medicine products, perfumes, photography equipment, household goods, food, miscellaneous items, and others.
Show moreShow less
It is also involved in the provision of maintenance and surveillance services, and medical services; operation service of distribution centers; management, logistics, and personnel services; maintenance and repair of furniture; transport and distribution of goods; purchase, sale, and rental of buildings; and manufacture and packaging of non-alcoholic beverages.
The company was founded in 1942 and is based in Guadalajara, Mexico.
Stock analysis
Corporativo Fragua S.A.B. de C.V (FRAGUAB) currently trades at 415.00 MXN, while our model-based Fair Value estimate is 744.58 MXN, implying the stock looks roughly 44% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 1,075 MXN per share, and 16 of the 24 models we run sit above the 415.00 MXN price.
Bear case: the Dividend Discount group reads lowest at 177.29 MXN, and 8 of the 24 models stay below the price. Data coverage for this calculation is medium.
Scenario range: 394.62 MXN (bear) to 1,147 MXN (bull), the price of 415.00 MXN sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 53/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Corporativo Fragua S.A.B. de C.V reported revenue of 120B MXN in FY2024 versus 73.3B MXN in FY2020, a compound +13.2%/yr. Reported net income was 4.9B MXN in FY2024, compounding +24.7%/yr from FY2020.
Key figures
Market cap 40.2B MXN (≈ $2.2B) Mid · P/E ratio 9.3 · P/S ratio 0.29 · EPS (TTM) 44.25 MXN · Net margin 3.3% · Return on equity 16.1% · Return on assets (EBIT) 8.0% · Operating margin 5.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 47 out of 100 (low confidence).
What moves the price
The share trades about 25% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 25% fair-value upside, at 79%, FRAGUAB screens cheaper than that median.
Fair Value models
Bear394.62 MXNFair Value 744.58 MXNBull1,147 MXN
Price 415.00 MXN · Upside +79.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2024 figures (about 12 months old). Earnings retained since then (44.25 MXN per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.67/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+9.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.2%
Revenue growth 24 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.7%
’13
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
What shareholders gained per year (last 5 years), in MXN (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip. Measured in MXN: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+23.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year+23.8%
Dividend (yield on the price)0.0%
Profit margin 2019 to 2024 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.5% → 4%
2024 sits 62% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Growth Forecast
A lot of optimism in the price
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
more than +80 %
Yearly growth needed for the next five years to justify today's price.
Compare Corporativo Fragua S.A.B. de C.V with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Pharmaceutical Retailers · 50 stocks
Beats the industry median on 11/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score53 · Below median
Fair Value upside+79.4% · Top 25%
Profitability
Return on equity (12 months)16.1% · Top 25%
Return on assets8.5% · Top 25%
Net margin (12 months)3.3% · Above median
Operating margin (12 months)5.7% · Above median
Growth and dividend
Revenue growth (quarter YoY)6.5% · Above median
Dividend yield (12 months)0.0% · Bottom 25%
Balance sheet
Debt / equity0.00× · Below median
Valuation Multiplesvs Pharmaceutical Retailers median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Corporativo Fragua S.A.B. de C.V Fair Value". https://www.fairvalue-calculator.com/stock/FRAGUAB
Frequently asked questions
Is Corporativo Fragua S.A.B. de C.V (FRAGUAB) overvalued or undervalued?
As of Nov 1, 2026, our model estimates a fair value of 744.58 MXN versus a price of 415.00 MXN, about +79% upside (undervalued).
What is the fair value of FRAGUAB?
Our model-based fair value for Corporativo Fragua S.A.B. de C.V is 744.58 MXN (as of Nov 1, 2026), built from audited fundamentals. The current price: 415.00 MXN.
What is the quality score of FRAGUAB?
Corporativo Fragua S.A.B. de C.V has a Quality Score of 53/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Corporativo Fragua S.A.B. de C.V (FRAGUAB)?
Our model-based price target is the fair value of 744.58 MXN (as of Nov 1, 2026) from 24 valuation models. Cautious scenario 394.62 MXN, optimistic scenario 1,147 MXN. It is a calculation from audited fundamentals, not an analyst target.
What is the Corporativo Fragua S.A.B. de C.V stock forecast for 2026?
Our models put fair value at 744.58 MXN, about +79% upside versus a price of 415.00 MXN (undervalued). Cautious scenario 394.62 MXN, optimistic scenario 1,147 MXN. The calculation is refreshed regularly with new filings.
What is the revenue of Corporativo Fragua S.A.B. de C.V (FRAGUAB)?
Corporativo Fragua S.A.B. de C.V reported trailing-twelve-month revenue of about 137B MXN (latest available figure, as of Nov 1, 2026).
What growth is priced into Corporativo Fragua S.A.B. de C.V (FRAGUAB)?
For today's price to be fair in a discounted-cash-flow model, Corporativo Fragua S.A.B. de C.V would have to grow free cash flow by more than 80 % per year for five years (discount rate 10.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +14.2 % per year. As of Nov 1, 2026.
What discount rate (WACC) does the fair value of FRAGUAB use?
Our models discount Corporativo Fragua S.A.B. de C.V at 10.5 %: a base by market capitalisation (mid), damped by beta 0.08, country premium for Mexico. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Corporativo Fragua S.A.B. de C.V that is more than 80 % per year a year over ten years, using the same discount rate (10.5 %) and the same formula as our fair value.
How much growth has Corporativo Fragua S.A.B. de C.V (FRAGUAB) delivered so far?
Over the past 5 years revenue at Corporativo Fragua S.A.B. de C.V grew +14.2 % a year. The price currently implies more than 80 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Corporativo Fragua S.A.B. de C.V (FRAGUAB) growing?
The median revenue growth in the sector is +3.4 % a year. That is the yardstick for the growth priced into Corporativo Fragua S.A.B. de C.V (more than 80 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Corporativo Fragua S.A.B. de C.V (FRAGUAB)?
The free-cash-flow yield on the price is 0.14 %: that much free cash flow Corporativo Fragua S.A.B. de C.V produces per unit of market value. When it exceeds the discount rate of our models (10.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Corporativo Fragua S.A.B. de C.V (FRAGUAB)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Corporativo Fragua S.A.B. de C.V it is 744.58 MXN per share (as of Nov 1, 2026), against a price of 415.00 MXN. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Corporativo Fragua S.A.B. de C.V stock overvalued or undervalued in 2026?
As of Nov 1, 2026, FRAGUAB trades below its calculated fair value: price 415.00 MXN, fair value 744.58 MXN, a gap of about +79% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of FRAGUAB?
No. The price is what the market pays today (415.00 MXN); the fair value is what the company's own numbers justify (744.58 MXN). For Corporativo Fragua S.A.B. de C.V the two are 329.58 MXN per share apart. That gap is exactly why we show both numbers side by side.
How much is Corporativo Fragua S.A.B. de C.V worth?
The market values Corporativo Fragua S.A.B. de C.V at about 40.2B MXN (market capitalisation, as of Nov 1, 2026). Per share that is 415.00 MXN; our models calculate a fair value of 744.58 MXN per share.
What do the bullish and bearish scenarios say about FRAGUAB?
Our models span a range for Corporativo Fragua S.A.B. de C.V: cautious scenario 394.62 MXN, base 744.58 MXN, optimistic 1,147 MXN per share (as of Nov 1, 2026, price 415.00 MXN). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of FRAGUAB?
Corporativo Fragua S.A.B. de C.V trades at a price-to-earnings ratio of 9.3 (as of Nov 1, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 744.58 MXN is built from several models across several years. Median P/E at fiscal year-end, 9 fiscal years (2016 to 2024), reported earnings: 13.4. Other multiples: P/B 1.6, P/S 0.3, EV/EBITDA 4.0.
How solid is the balance sheet of Corporativo Fragua S.A.B. de C.V (FRAGUAB)?
Balance-sheet figures for Corporativo Fragua S.A.B. de C.V (as of Nov 1, 2026): return on equity 16.1%, debt of 0.00 per unit of equity. They feed the Quality Score of 53/100, which measures business quality independently of the share price.
How far is FRAGUAB from its 52-week high?
Corporativo Fragua S.A.B. de C.V trades at 415.00 MXN, about 25% below its 52-week high of 551.69 MXN and at the low of 413.41 MXN (as of Nov 3, 2026). Distance from the high says nothing about value: that is what the fair value of 744.58 MXN is for.
Which stocks are comparable to Corporativo Fragua S.A.B. de C.V?
From the same area (Healthcare) we also value JD Health International Inc, Alibaba Health Information Technology Limited, Yifeng Pharmacy Chain Co, DaShenLin Pharmaceutical Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Corporativo Fragua S.A.B. de C.V stock attractive at the current price?
The data as of Nov 1, 2026: price 415.00 MXN, calculated fair value 744.58 MXN (+79%), Quality Score 53/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of FRAGUAB calculated?
We run Corporativo Fragua S.A.B. de C.V through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 744.58 MXN, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5% above its aggregate fair value. Corporativo Fragua S.A.B. de C.V currently trades 44% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Corporativo Fragua S.A.B. de C.V (FRAGUAB)?
The closing price on Nov 3, 2026 was 415.00 MXN. Our model-based fair value is 744.58 MXN, about +79% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Corporativo Fragua S.A.B. de C.V right now?
The model range is unusually wide (394.62 MXN to 1,147 MXN). The outcome hinges heavily on assumptions, so read the point estimate with caution. Solid quality (53/100) at a price below fair value, the discount is the argument here, not the business quality.
Key figures of Corporativo Fragua S.A.B. de C.V
How large is the market capitalisation of Corporativo Fragua S.A.B. de C.V (FRAGUAB)?
The market capitalisation of Corporativo Fragua S.A.B. de C.V is 40.2B MXN (≈ $2.2B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Corporativo Fragua S.A.B. de C.V (FRAGUAB)?
The price-to-sales ratio of Corporativo Fragua S.A.B. de C.V is 0.29 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Corporativo Fragua S.A.B. de C.V (FRAGUAB)?
Earnings per share at Corporativo Fragua S.A.B. de C.V are 44.25 MXN (price ÷ EPS = P/E 9.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Corporativo Fragua S.A.B. de C.V (FRAGUAB)?
The net margin of Corporativo Fragua S.A.B. de C.V is 3.3% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Corporativo Fragua S.A.B. de C.V (FRAGUAB)?
The return on equity (ROE) of Corporativo Fragua S.A.B. de C.V is 16.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Corporativo Fragua S.A.B. de C.V (FRAGUAB)?
On an EBIT basis the return on assets of Corporativo Fragua S.A.B. de C.V is 8.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Corporativo Fragua S.A.B. de C.V (FRAGUAB)?
The operating margin of Corporativo Fragua S.A.B. de C.V is 5.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Corporativo Fragua S.A.B. de C.V (FRAGUAB)?
Revenue at Corporativo Fragua S.A.B. de C.V is growing +6.5% versus a year earlier (3y avg +12.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Corporativo Fragua S.A.B. de C.V (FRAGUAB)?
Earnings per share at Corporativo Fragua S.A.B. de C.V are growing −2.0% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed
Watch Corporativo Fragua S.A.B. de C.V in the live analysis
One click puts Corporativo Fragua S.A.B. de C.V on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 1, 2026